Clinical Trials in San Antonio

Showing 9241-9260 of 14,633 trials

Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age

NCT02022956

The purpose of this study is to evaluate the PK properties, tolerability, and safety of lorcaserin HCL (BELVIQ) in obese adolescent subjects between the ages of 12 to 17 years old

Pharmacokinetics in Obese Adolescents

Eisai Inc.8 participantsStarted Dec 2013

Philadelphia, Pennsylvania, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

NCT00355849

A study to evaluate the efficacy and safety of Human Insulin Inhalation Powder \[also known as AIR® Inhaled Insulin\]\[AIR® is a registered trademark of Alkermes,Inc.\] in patients with Type 2 diabetes who are currently being treated with once daily insulin glargine injections. The present study is intended to determine if mealtime AIR® Insulin may be superior to once-daily insulin glargine injections.

Diabetes Mellitus, Type 2

Eli Lilly and Company555 participantsStarted Aug 2006

Fresno, California, United States • Pomona, California, United States • West Palm Beach, Florida, United States +66 more locations

Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

Find Trials by Condition in San Antonio

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

A Study LY2228820 for Recurrent Ovarian Cancer

A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

A Study of Advanced or Metastatic Non-small Cell Lung Cancer

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

A Study in Advanced Cancer

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

The Patient-Reported Outcomes Project of HCV-TARGET

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer